An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6505-6514

  Kominsky, Douglas J ^a   Keely, Simon ^a   MacManus, Christopher F ^a   Glover, Louise E ^a   Scully, Melanie ^a   Collins, Colm B ^a,b   Bowers, Brittelle E ^a   Campbell, Eric L ^a   Colgan, Sean P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSYLHOMOCYSTEINASE; BETAINE; CHOLINE; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL; LACTIC ACID; METHIONINE ADENOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE EXACERBATION; DNA METHYLATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLISM; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENINE; ADENOSYLHOMOCYSTEINASE; ANIMALS; BLOTTING, WESTERN; BUTYRIC ACIDS; CELL LINE, TUMOR; COLITIS; COLON; DEXTRAN SULFATE; DNA METHYLATION; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; METHIONINE ADENOSYLTRANSFERASE; METHYLATION; MICE; MICE, INBRED C57BL; MUCOSITIS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79958025266     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002805     Document Type: Article

References (65)

1. Xavier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Baumgart, D. C., and S. R. Carding. 2007. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
3. Sartor, R. B. 1995. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North Am. 24: 475-507.
4. Danese, S., E. Dejana, and C. Fiocchi. 2007. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 178: 6017-6022. (Pubitemid 46717378)
5. Hatoum, O. A., D. G. Binion, and D. D. Gutterman. 2005. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur. J. Clin. Invest. 35: 599-609.
6. Haddad, J. J. 2003. Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxiainducible factor-1a. Crit. Care 7: 47-54. (Pubitemid 36204269)
7. Kokura, S., N. Yoshida, and T. Yoshikawa. 2002. Anoxia/reoxygenation- induced leukocyte-endothelial cell interactions. Free Radic. Biol. Med. 33: 427-432.
8. Saadi, S., L. E. Wrenshall, and J. L. Platt. 2002. Regional manifestations and control of the immune system. FASEB J. 16: 849-856.
9. Lewis, J. S., J. A. Lee, J. C. Underwood, A. L. Harris, and C. E. Lewis. 1999. Macrophage responses to hypoxia: relevance to disease mechanisms. J. Leukoc. Biol. 66: 889-900.
10. Kominsky, D. J., E. L. Campbell, and S. P. Colgan. 2010. Metabolic shifts in immunity and inflammation. J. Immunol. 184: 4062-4068.
11. Baldessarini, R. J. 1987. Neuropharmacology of S-adenosyl-L-methionine. Am. J. Med. 83(5A): 95-103.
12. Cantoni, G., and P. Chiang. 1980. The role of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biological methylations. In Natural Sulfur Compounds: Novel Biochemical and Structural Aspects. D. Cavallini, G. E. Gaull, and V. Zappia, eds. New York: , Plenum Press, p. 67-80.
13. Cantoni, G. L., and E. Scarano. 1954. The formation of S-adenosylhomocysteine in enzymatic transmethylation reactions. J. Am. Chem. Soc. 76: 4744.
14. Clarke, S., and K. Banfield. 2001. S-Adenosylmethionine-dependent methyltransferases. In Homocysteine in Health and Disease, R. Carmel, and D. W. Jacobsen, eds., eds. Cambridge University Press, New York, p. 63-78.
15. Chiang, P. K. 1998. Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol. Ther. 77: 115-134.
16. Wolos, J. A., K. A. Frondorf, G. F. Babcock, S. A. Stripp, and T. L. Bowlin. 1993. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. Cell. Immunol. 149: 402-408.
17. Fu, Y. F., J. X. Wang, Y. Zhao, Y. Yang, W. Tang, J. Ni, Y. N. Zhu, R. Zhou, P. L. He, C. Li, et al. 2006. S-Adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses. J. Pharmacol. Exp. Ther. 316: 1229-1237.
18. Fu, Y. F., Y. N. Zhu, J. Ni, X. G. Zhong, W. Tang, Y. D. Re, L. P. Shi, J. Wan, Y. F. Yang, C. Yuan, et al. 2006. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. J. Pharmacol. Exp. Ther. 319: 799-808.
19. Lawson, B. R., Y. Manenkova, J. Ahamed, X. Chen, J. P. Zou, R. Baccala, A. N. Theofilopoulos, and C. Yuan. 2007. Inhibition of transmethylation downregulates CD4 T cell activation and curtails development of autoimmunity in a model system. J. Immunol. 178: 5366-5374. (Pubitemid 46595323)
20. Saso, Y., E. M. Conner, B. R. Teegarden, and C. S. Yuan. 2001. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. J. Pharmacol. Exp. Ther. 296: 106-112.
21. Wu, Q. L., Y. F. Fu, W. L. Zhou, J. X. Wang, Y. H. Feng, J. Liu, J. Y. Xu, P. L. He, R. Zhou, W. Tang, et al. 2005. Inhibition of S-adenosyl-L- homocysteine hydrolase induces immunosuppression. J. Pharmacol. Exp. Ther. 313: 705-711.
22. Khoury, J., J. C. Ibla, A. S. Neish, and S. P. Colgan. 2007. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J. Clin. Invest. 117: 703-711.
23. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
24. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
25. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702. (Pubitemid 20069706)
26. Magness, S. T., H. Jijon, N. Van Houten Fisher, N. E. Sharpless, D. A. Brenner, and C. Jobin. 2004. In vivo pattern of lipopolysaccharide and anti - CD3-induced NF-κB activation using a novel gene-targeted enhanced GFP reporter gene mouse. J. Immunol. 173: 1561-1570.
27. Watson, J. A., C. J. Watson, A. M. McCrohan, K. Woodfine, M. Tosetto, J. McDaid, E. Gallagher, D. Betts, J. Baugh, J. O'Sullivan, et al. 2009. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum. Mol. Genet. 18: 3594-3604.
28. Gottschalk, S., N. Anderson, C. Hainz, S. G. Eckhardt, and N. J. Serkova. 2004. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL - positive cells. Clin. Cancer Res. 10: 6661-6668.
29. Serkova, N., T. F. Fuller, J. Klawitter, C. E. Freise, and C. U. Niemann. 2005. HNMR - based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 67: 1142-1151.
30. Hartmann, G., C. Bidlingmaier, B. Siegmund, S. Albrich, J. Schulze, K. Tschoep, A. Eigler, H. A. Lehr, and S. Endres. 2000. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J. Pharmacol. Exp. Ther. 292: 22-30.
31. Furuta, G. T., J. R. Turner, C. T. Taylor, R. M. Hershberg, K. Comerford, S. Narravula, D. K. Podolsky, and S. P. Colgan. 2001. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193: 1027-1034.
32. Karhausen, J., G. T. Furuta, J. E. Tomaszewski, R. S. Johnson, S. P. Colgan, and V. H. Haase. 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114: 1098-1106.
33. Robinson, A., S. Keely, J. Karhausen, M. E. Gerich, G. T. Furuta, and S. P. Colgan. 2008. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134: 145-155.
34. Berg, S., P. L. Sappington, L. J. Guzik, R. L. Delude, and M. P. Fink. 2003. Proinflammatory cytokines increase the rate of glycolysis and adenosine-5′-triphosphate turnover in cultured rat enterocytes. Crit. Care Med. 31: 1203-1212.
35. Scharte, M., X. Han, D. J. Bertges, M. P. Fink, and R. L. Delude. 2003. Cytokines induce HIF-1 DNA binding and the expression of HIF-1 - dependent genes in cultured rat enterocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G373-G384.
36. Li, X., and G. R. Stark. 2002. NFκB-dependent signaling pathways. Exp. Hematol. 30: 285-296.
37. Werner, S. L., D. Barken, and A. Hoffmann. 2005. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309: 1857-1861. (Pubitemid 41325096)
38. Cockman, M. E., D. E. Lancaster, I. P. Stolze, K. S. Hewitson, M. A. McDonough, M. L. Coleman, C. H. Coles, X. Yu, R. T. Hay, S. C. Ley, et al. 2006. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. USA 103: 14767-14772.
39. Cummins, E. P., E. Berra, K. M. Comerford, A. Ginouves, K. T. Fitzgerald, F. Seeballuck, C. Godson, J. E. Nielsen, P. Moynagh, J. Pouyssegur, and C. T. Taylor. 2006. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFkB activity. Proc. Natl. Acad. Sci. USA 103: 18154-18159.
40. Chen, L. W., L. Egan, Z. W. Li, F. R. Greten, M. F. Kagnoff, and M. Karin. 2003. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9: 575-581.
41. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296. (Pubitemid 39061110)
42. Vanden Berghe, W., M. N. Ndlovu, R. Hoya-Arias, N. Dijsselbloem, S. Gerlo, and G. Haegeman. 2006. Keeping up NF-κB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochem. Pharmacol. 72: 1114-1131.
43. Cummins, E. P., F. Seeballuck, S. J. Keely, N. E. Mangan, J. J. Callanan, P. G. Fallon, and C. T. Taylor. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165.
44. Miller, M. W., D. M. Duhl, B. M. Winkes, F. Arredondo-Vega, P. J. Saxon, G. L. Wolff, C. J. Epstein, M. S. Hershfield, and G. S. Barsh. 1994. The mouse lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 13: 1806-1816.
45. Eckmann, L., T. Nebelsiek, A. A. Fingerle, S. M. Dann, J. Mages, R. Lang, S. Robine, M. F. Kagnoff, R. M. Schmid, M. Karin, et al. 2008. Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA 105: 15058-15063.
46. Zaph, C., A. E. Troy, B. C. Taylor, L. D. Berman-Booty, K. J. Guild, Y. Du, E. A. Yost, A. D. Gruber, M. J. May, F. R. Greten, et al. 2007. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446: 552-556. (Pubitemid 46514719)
47. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096-21103.
48. Cummins, E. P., F. Seeballuck, S. J. Keely, N. E. Mangan, J. J. Callanan, P. G. Fallon, and C. T. Taylor. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165.
49. Erzin, Y., H. Uzun, A. F. Celik, S. Aydin, A. Dirican, and H. Uzunismail. 2008. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications. J. Clin. Gastroenterol. 42: 481-486.
50. 12 and folate status in patients with inflammatory bowel diseases. Eur. J. Intern. Med. 21: 320-323.
51. Zezos, P., G. Papaioannou, N. Nikolaidis, T. Vasiliadis, O. Giouleme, and N. Evgenidis. 2005. Hyperhomocysteinemia in ulcerative colitis is related to folate levels. World J. Gastroenterol. 11: 6038-6042.
52. Chen, M., L. Peyrin-Biroulet, A. George, F. Coste, A. Bressenot, C. Bossenmeyer-Pourie, J. M. Alberto, B. Xia, B. Namour, and J. L. Gueant. Methyl-deficient diet aggravates experimental colitis in rats. J. Cell. Mol. Med. In press.
53. Taylor, C. T., and S. P. Colgan. 2007. Hypoxia and gastrointestinal disease. J. Mol. Med. 85: 1295-1300.
54. Semenza, G. L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 24: 97-106.
55. Tormos, K. V., and N. S. Chandel. 2010. Inter-connection between mitochondria and HIFs. J. Cell. Mol. Med. 14: 795-804.
56. Morgan, H. D., F. Santos, K. Green, W. Dean, and W. Reik. 2005. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 14(Spec No 1): R47-R58.
57. Trojer, P., and D. Reinberg. 2006. Histone lysine demethylases and their impact on epigenetics. Cell 125: 213-217.
58. Halim, A. B., L. LeGros, M. E. Chamberlin, A. Geller, and M. Kotb. 2001. Regulation of the human MAT2A gene encoding the catalytic a2 subunit of methionine adenosyltransferase, MAT II: gene organization, promoter characterization, and identification of a site in the proximal promoter that is essential for its activity. J. Biol. Chem. 276: 9784-9791.
59. Yang, H., M. R. Sadda, V. Yu, Y. Zeng, T. D. Lee, X. Ou, L. Chen, and S. C. Lu. 2003. Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor α: role of NF-κB and AP-1. J. Biol. Chem. 278: 50887-50896. (Pubitemid 38020319)
60. Gough, D. J., D. E. Levy, R. W. Johnstone, and C. J. Clarke. 2008. IFNγ signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev. 19: 383-394.
61. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
62. Taylor, C. T., and E. P. Cummins. 2009. The role of NF-κB in hypoxia-induced gene expression. Ann. N. Y. Acad. Sci. 1177: 178-184.
63. Hirata, I., S. Yasumoto, K. Toshina, T. Inoue, T. Nishikawa, N. Murano, M. Murano, F. Y. Wang, and K. Katsu. 2007. Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate-induced colitis. World J. Gastroenterol. 13: 1666-1671.
64. Schmidt, N., E. Gonzalez, A. Visekruna, A. A. Kühl, C. Loddenkemper, H. Mollenkopf, S. H. Kaufmann, U. Steinhoff, and T. Joeris. 2010. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 59: 896-906.
65. Zhang, D. K., L. N. Cheng, X. L. Huang, W. Shi, J. Y. Xiang, and H. T. Gan. 2009. Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor-κB activation. Int. J. Colorectal Dis. 24: 5-12.